Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weiying Yang

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Annals of Nutrition & Metabolism|March 30, 2026
Incidence of Osteoporotic Fractures in Rheumatoid Arthritis: A Systematic Review and Meta-AnalysisQianqian Dai, Yingying Jin, Yilu Ren, et al.
Parasites & Vectors|November 2, 2024
Development of a LAMP assay for the rapid visual detection of the emerging tick-borne Songling virusZheng Gui, Yuanning Ren, Qiqi Guo, et al.
Journal of Medicinal Chemistry|February 3, 2006
Novel potent hepatitis C virus NS3 serine protease inhibitors derived from proline-based macrocyclesKevin X Chen, F George Njoroge, Ashok Arasappan, et al.
Journal of Medicinal Chemistry|February 7, 2009
Second-generation highly potent and selective inhibitors of the hepatitis C virus NS3 serine proteaseKevin X Chen, Latha Nair, Bancha Vibulbhan, et al.
Journal of Medicinal Chemistry|January 18, 2012
A novel class of highly potent irreversible hepatitis C virus NS5B polymerase inhibitorsKevin X Chen, Charles A Lesburg, Bancha Vibulbhan, et al.
Journal of Medicinal Chemistry|December 14, 2011
Structure-activity relationship (SAR) development and discovery of potent indole-based inhibitors of the hepatitis C virus (HCV) NS5B polymeraseKevin X Chen, Bancha Vibulbhan, Weiying Yang, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Narlaprevir (SCH 900518): A Potent, Second Generation HCV NS3 Serine Protease InhibitorAshok Arasappan, Frank Bennett, Stephane L Bogen, et al.
Journal of Medicinal Chemistry|September 29, 2006
Discovery of (1R,5S)-N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]- 3-[2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (SCH 503034), a selective, potent, orally bioavailable hepatitis C virus NS3 protease inhibitor: a potential therapeutic agent for the treatment of hepatitis C infectionSrikanth Venkatraman, Stéphane L Bogen, Ashok Arasappan, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Annals of Nutrition & Metabolism|March 30, 2026
Incidence of Osteoporotic Fractures in Rheumatoid Arthritis: A Systematic Review and Meta-AnalysisQianqian Dai, Yingying Jin, Yilu Ren, et al.
Parasites & Vectors|November 2, 2024
Development of a LAMP assay for the rapid visual detection of the emerging tick-borne Songling virusZheng Gui, Yuanning Ren, Qiqi Guo, et al.
Journal of Medicinal Chemistry|February 3, 2006
Novel potent hepatitis C virus NS3 serine protease inhibitors derived from proline-based macrocyclesKevin X Chen, F George Njoroge, Ashok Arasappan, et al.
Journal of Medicinal Chemistry|February 7, 2009
Second-generation highly potent and selective inhibitors of the hepatitis C virus NS3 serine proteaseKevin X Chen, Latha Nair, Bancha Vibulbhan, et al.
Journal of Medicinal Chemistry|January 18, 2012
A novel class of highly potent irreversible hepatitis C virus NS5B polymerase inhibitorsKevin X Chen, Charles A Lesburg, Bancha Vibulbhan, et al.
Journal of Medicinal Chemistry|December 14, 2011
Structure-activity relationship (SAR) development and discovery of potent indole-based inhibitors of the hepatitis C virus (HCV) NS5B polymeraseKevin X Chen, Bancha Vibulbhan, Weiying Yang, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Narlaprevir (SCH 900518): A Potent, Second Generation HCV NS3 Serine Protease InhibitorAshok Arasappan, Frank Bennett, Stephane L Bogen, et al.
Journal of Medicinal Chemistry|September 29, 2006
Discovery of (1R,5S)-N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]- 3-[2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (SCH 503034), a selective, potent, orally bioavailable hepatitis C virus NS3 protease inhibitor: a potential therapeutic agent for the treatment of hepatitis C infectionSrikanth Venkatraman, Stéphane L Bogen, Ashok Arasappan, et al.
Pageof 3